Suzuki, R.; Ohkuma, R.; Watanabe, M.; Mura, E.; Tsurui, T.; Iriguchi, N.; Ishiguro, T.; Hirasawa, Y.; Ikeda, G.; Shimokawa, M.;
et al. Eosinophils and the Efficacy of Immune Checkpoint Inhibitors Across Multiple Cancers: A Retrospective Study. Biomedicines 2025, 13, 3029.
https://doi.org/10.3390/biomedicines13123029
AMA Style
Suzuki R, Ohkuma R, Watanabe M, Mura E, Tsurui T, Iriguchi N, Ishiguro T, Hirasawa Y, Ikeda G, Shimokawa M,
et al. Eosinophils and the Efficacy of Immune Checkpoint Inhibitors Across Multiple Cancers: A Retrospective Study. Biomedicines. 2025; 13(12):3029.
https://doi.org/10.3390/biomedicines13123029
Chicago/Turabian Style
Suzuki, Risako, Ryotaro Ohkuma, Makoto Watanabe, Emiko Mura, Toshiaki Tsurui, Nana Iriguchi, Tomoyuki Ishiguro, Yuya Hirasawa, Go Ikeda, Masahiro Shimokawa,
and et al. 2025. "Eosinophils and the Efficacy of Immune Checkpoint Inhibitors Across Multiple Cancers: A Retrospective Study" Biomedicines 13, no. 12: 3029.
https://doi.org/10.3390/biomedicines13123029
APA Style
Suzuki, R., Ohkuma, R., Watanabe, M., Mura, E., Tsurui, T., Iriguchi, N., Ishiguro, T., Hirasawa, Y., Ikeda, G., Shimokawa, M., Ariizumi, H., Kubota, Y., Yoshimura, K., Kobayashi, S., Tsunoda, T., Horiike, A., Tsuji, M., Kiuchi, Y., Oguchi, T.,
& Wada, S.
(2025). Eosinophils and the Efficacy of Immune Checkpoint Inhibitors Across Multiple Cancers: A Retrospective Study. Biomedicines, 13(12), 3029.
https://doi.org/10.3390/biomedicines13123029
